XML 89 R68.htm IDEA: XBRL DOCUMENT v2.4.0.6
BUSINESS COMBINATIONS (Details 7)
0 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Sep. 15, 2011
Sanitas
USD ($)
Aug. 19, 2011
Sanitas
USD ($)
Jul. 31, 2011
Sanitas
USD ($)
Dec. 31, 2012
Sanitas
USD ($)
item
Dec. 31, 2011
Sanitas
USD ($)
Sep. 22, 2011
Sanitas
Sep. 15, 2011
Sanitas
EUR (€)
Dec. 31, 2011
Sanitas
Amounts Recognized as of Acquisition Date (as previously reported)
USD ($)
Dec. 31, 2011
Sanitas
Amounts Recognized (as adjusted)
USD ($)
Dec. 31, 2012
Sanitas
Product brands
Dec. 31, 2011
Sanitas
Product brands
Amounts Recognized (as adjusted)
USD ($)
Dec. 31, 2012
Sanitas
Product rights
Dec. 31, 2011
Sanitas
Product rights
Amounts Recognized (as adjusted)
USD ($)
Dec. 31, 2012
Sanitas
Corporate brands
Dec. 31, 2011
Sanitas
Corporate brands
Amounts Recognized (as adjusted)
USD ($)
Dec. 31, 2012
Sanitas
Partner relationships
Dec. 31, 2011
Sanitas
Partner relationships
Amounts Recognized (as adjusted)
USD ($)
Business Combinations                                      
Additional outstanding common shares acquired, percentage     6.40% 87.20% 4.80%                            
Additional cash consideration paid     $ 27,400,000 $ 392,300,000                              
Additional outstanding common shares acquired     1,968,631   1,502,432                            
Outstanding common shares acquired, percentage       92.00%         98.40%                    
Outstanding common shares acquired       28,625,025         30,593,656                    
Noncontrolling interest, percent       8.00%       1.60%                      
Noncontrolling interest, fair value       34,800,000 21,100,000                            
Unrealized loss reclassified from other comprehensive income to earnings       200,000                              
Purchase price per share (in euros per share)                 € 10.06                    
Noncontrolling interest, number of shares               512,264                      
Amount due shareholders of acquiree 981,282,000 527,583,000       2,400,000                          
Number of products in product portfolio           390                          
Number of countries of operation           9                          
Assets acquired and liabilities assumed                                      
Cash and cash equivalents                   5,607,000                  
Accounts receivable                   25,645,000                  
Inventories                   22,010,000                  
Other current assets                   3,166,000                  
Property, plant and equipment                   83,288,000                  
Identifiable intangible assets, excluding acquired IPR&D                   247,127,000 247,127,000   164,823,000   43,027,000   25,227,000   14,050,000
Acquired IPR&D 546,876,000 531,304,000               747,000                  
Other non-current assets                   2,662,000                  
Current liabilities                   (30,428,000)                  
Long-term debt, including current portion                   (67,134,000)                  
Deferred income taxes, net                   (43,269,000)                  
Other non-current liabilities                   (6,049,000)                  
Total identifiable net assets                   243,372,000                  
Goodwill                   204,791,000                  
Total fair value of consideration transferred                   448,163,000                  
Fair value of trade accounts receivable acquired             25,600,000                        
Gross contractual amount of trade accounts receivable acquired             27,800,000                        
Expected uncollectible of trade accounts receivable acquired             $ 2,200,000                        
Estimated weighted-average useful life           8 years           7 years   7 years   15 years   7 years